Aspen Pharmacare Holdings (STU:LDZA) Cash And Cash Equivalents : €571 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Aspen Pharmacare Holdings Cash And Cash Equivalents?

Aspen Pharmacare Holdings's quarterly cash and cash equivalents increased from Dec. 2022 (€439.50 Mil) to Jun. 2023 (€537.31 Mil) and increased from Jun. 2023 (€537.31 Mil) to Dec. 2023 (€570.79 Mil).

Aspen Pharmacare Holdings's annual cash and cash equivalents declined from Jun. 2021 (€509.82 Mil) to Jun. 2022 (€369.86 Mil) but then increased from Jun. 2022 (€369.86 Mil) to Jun. 2023 (€537.31 Mil).

Aspen Pharmacare Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Aspen Pharmacare Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Cash And Cash Equivalents Chart

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash And Cash Equivalents

Get a 7-Day Free Trial

544.71

367.60

509.82

369.86

537.31

Aspen Pharmacare Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															438.61	369.86	439.50	537.31	570.79

Aspen Pharmacare Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Aspen Pharmacare Holdings (STU:LDZA) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Aspen Pharmacare Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspen Pharmacare Holdings (STU:LDZA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (STU:LDZA) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

APN:South Africa APNHY:USA

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (STU:LDZA) Headlines

No Headlines